CN115917002A - 病原体诊断测试 - Google Patents

病原体诊断测试 Download PDF

Info

Publication number
CN115917002A
CN115917002A CN202180040815.0A CN202180040815A CN115917002A CN 115917002 A CN115917002 A CN 115917002A CN 202180040815 A CN202180040815 A CN 202180040815A CN 115917002 A CN115917002 A CN 115917002A
Authority
CN
China
Prior art keywords
nucleic acid
sequence
coronavirus
synthetic
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180040815.0A
Other languages
English (en)
Chinese (zh)
Inventor
斯里拉姆·库苏里
埃里克·马修·琼斯
艾伦·库珀
莫利·珍妮特·加斯佩里尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Okotant
Original Assignee
Okotant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okotant filed Critical Okotant
Publication of CN115917002A publication Critical patent/CN115917002A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN202180040815.0A 2020-04-06 2021-04-05 病原体诊断测试 Pending CN115917002A (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063005996P 2020-04-06 2020-04-06
US63/005,996 2020-04-06
US202063062406P 2020-08-06 2020-08-06
US63/062,406 2020-08-06
US202163136449P 2021-01-12 2021-01-12
US63/136,449 2021-01-12
US202163154571P 2021-02-26 2021-02-26
US63/154,571 2021-02-26
PCT/US2021/025806 WO2021207091A1 (en) 2020-04-06 2021-04-05 Pathogen diagnostic test

Publications (1)

Publication Number Publication Date
CN115917002A true CN115917002A (zh) 2023-04-04

Family

ID=75675001

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180040815.0A Pending CN115917002A (zh) 2020-04-06 2021-04-05 病原体诊断测试

Country Status (11)

Country Link
US (2) US12129523B2 (https=)
EP (2) EP4286538A3 (https=)
JP (1) JP7801240B2 (https=)
KR (1) KR20220164745A (https=)
CN (1) CN115917002A (https=)
AU (1) AU2021251703A1 (https=)
BR (1) BR112022020143A2 (https=)
CA (1) CA3179579A1 (https=)
IL (1) IL297033A (https=)
MX (1) MX2022012516A (https=)
WO (1) WO2021207091A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230019965A (ko) * 2020-06-22 2023-02-09 주식회사 씨젠 검체 내 타겟 핵산 서열 검출을 위한 준비물을 제공하는 방법
CA3240812A1 (en) * 2021-12-22 2023-06-29 Carter BARGER Quality control for reporter screening assays
US12553093B1 (en) * 2025-03-26 2026-02-17 Wolf of Zion, Inc. Methods of detecting, identifying and quantifying wild spike protein and covid vaccine spike proteins

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265796A1 (en) * 2003-04-17 2004-12-30 Thomas Briese Methods and kits for detecting SARS-associated coronavirus
WO2007100397A2 (en) * 2005-11-28 2007-09-07 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious contaminant viruses
CN101384730A (zh) * 2005-12-23 2009-03-11 阿尔维德医药技术公司 用于传染病和癌症检测的分子信标成像的方法和应用
US20090181360A1 (en) * 2007-12-21 2009-07-16 Jules Chen Multiplex detection assay for influenza and rsv viruses
US20130266931A1 (en) * 2010-07-16 2013-10-10 Tocagen Inc. Retrovirus detection
US20160281131A1 (en) * 2014-10-08 2016-09-29 Theranos, Inc. Methods and Devices for Real-Time Diagnostic Testing (RDT) for Ebola and other Infectious Diseases
CN107922971A (zh) * 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
CN111494616A (zh) * 2020-04-27 2020-08-07 重庆医科大学附属永川医院 一种新冠病毒免疫增强型基因疫苗及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013006793A2 (en) 2011-07-06 2013-01-10 Quest Diagnostics Investments Incorporated Direct amplification and detection of viral and bacterial pathogens
JP2017209036A (ja) * 2016-05-24 2017-11-30 東洋紡株式会社 改良されたウイルス検出方法
JP7167913B2 (ja) 2017-04-26 2022-11-09 東洋紡株式会社 ウイルスの検査方法およびウイルスの検査用キット
JP7796660B2 (ja) * 2020-03-09 2026-01-09 エフ． ホフマン－ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス２（ｓａｒｓ－ｃｏｖ－２）、インフルエンザａ及びインフルエンザｂを検出するための組成物及び方法

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265796A1 (en) * 2003-04-17 2004-12-30 Thomas Briese Methods and kits for detecting SARS-associated coronavirus
WO2007100397A2 (en) * 2005-11-28 2007-09-07 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious contaminant viruses
CN101384730A (zh) * 2005-12-23 2009-03-11 阿尔维德医药技术公司 用于传染病和癌症检测的分子信标成像的方法和应用
US20090181360A1 (en) * 2007-12-21 2009-07-16 Jules Chen Multiplex detection assay for influenza and rsv viruses
US20130266931A1 (en) * 2010-07-16 2013-10-10 Tocagen Inc. Retrovirus detection
US20160281131A1 (en) * 2014-10-08 2016-09-29 Theranos, Inc. Methods and Devices for Real-Time Diagnostic Testing (RDT) for Ebola and other Infectious Diseases
CN107922971A (zh) * 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
CN111494616A (zh) * 2020-04-27 2020-08-07 重庆医科大学附属永川医院 一种新冠病毒免疫增强型基因疫苗及其制备方法

Also Published As

Publication number Publication date
WO2021207091A1 (en) 2021-10-14
MX2022012516A (es) 2023-01-19
JP2023520590A (ja) 2023-05-17
JP7801240B2 (ja) 2026-01-16
BR112022020143A2 (pt) 2023-02-28
EP4286538A3 (en) 2024-03-20
US12129523B2 (en) 2024-10-29
AU2021251703A1 (en) 2022-11-10
CA3179579A1 (en) 2021-10-14
EP4286538A2 (en) 2023-12-06
US20220356535A1 (en) 2022-11-10
IL297033A (en) 2022-12-01
EP4133103A1 (en) 2023-02-15
US20250084492A1 (en) 2025-03-13
KR20220164745A (ko) 2022-12-13

Similar Documents

Publication Publication Date Title
AU2019250200B2 (en) Error Suppression In Sequenced DNA Fragments Using Redundant Reads With Unique Molecular Indices (UMIs)
US20250084492A1 (en) Pathogen diagnostic test
Li et al. High sensitivity detection of SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method
JP2013531983A (ja) 多重生物検出のための核酸ならびにその使用および製造方法
US20240279751A1 (en) A rapid multiplex rpa based nanopore sequencing method for real-time detection and sequencing of multiple viral pathogens
JP2023519919A (ja) 病原体を検出するためのアッセイ
EP4229221B1 (en) Method for parallel nucleic acid analysis
WO2005059177A1 (en) A sensitive and specific test to detect sars coronavirus
HK40097173A (en) Pathogen diagnostic test
Jothikumar et al. Development and evaluation of a ligation-free sequence-independent, single-primer amplification (LF-SISPA) assay for whole genome characterization of viruses
Ge et al. Preferential amplification of pathogenic sequences
EP3985129A1 (en) Method for parallel nucleic acid analysis
US20250129438A1 (en) Assay for detection of sars-cov-2
Pichon et al. Evolution of influenza genome diversity during infection in immunocompetent patients
Arjmand et al. COVID-19 Diagnosis: A Comprehensive Review of Current Testing Platforms; Part A
Kalland et al. Molecular Microbial Diagnostics
Dai et al. One-Seq: A Highly Scalable Sequencing-Based Diagnostic for SARS-CoV-2 and Other Single-Stranded Viruses
Jancy et al. Next-Generation Sequencing in Viral Diagnosis
Senan et al. A rapid point-of-care population-scale dipstick assay to identify and differentiate SARS-CoV-2 variants in COVID-19-positive patients
Farraj Assay as a Diagnostic Tool for Infectious Disease
WO2022025824A1 (en) Methods for detecting rna viruses
HK40040528B (en) Error suppression in sequenced dna fragments using redundant reads with unique molecular indices (umis)
Lipkin et al. Pathogen surveillance and discovery

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination